- Home
- PESI vs INBX Comparison
PESI vs INBX Comparison
Compare PESI & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PESI
- INBX
- Stock Information
- Founded
- PESI 1990
- INBX 2010
- Country
- PESI United States
- INBX United States
- Employees
- PESI N/A
- INBX N/A
- Industry
- PESI Environmental Services
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- PESI Industrials
- INBX Health Care
- Exchange
- PESI Nasdaq
- INBX Nasdaq
- Market Cap
- PESI 186.4M
- INBX 178.5M
- IPO Year
- PESI 1992
- INBX 2020
- Fundamental
- Price
- PESI $11.42
- INBX $21.73
- Analyst Decision
- PESI
- INBX Hold
- Analyst Count
- PESI 0
- INBX 1
- Target Price
- PESI N/A
- INBX N/A
- AVG Volume (30 Days)
- PESI 111.7K
- INBX 120.3K
- Earning Date
- PESI 08-07-2025
- INBX 08-12-2025
- Dividend Yield
- PESI N/A
- INBX N/A
- EPS Growth
- PESI N/A
- INBX N/A
- EPS
- PESI N/A
- INBX 111.58
- Revenue
- PESI $59,419,000.00
- INBX $200,000.00
- Revenue This Year
- PESI $23.71
- INBX N/A
- Revenue Next Year
- PESI $86.33
- INBX N/A
- P/E Ratio
- PESI N/A
- INBX $0.20
- Revenue Growth
- PESI N/A
- INBX N/A
- 52 Week Low
- PESI $6.25
- INBX $10.80
- 52 Week High
- PESI $16.25
- INBX $22.28
- Technical
- Relative Strength Index (RSI)
- PESI 72.26
- INBX 84.22
- Support Level
- PESI $10.97
- INBX $13.97
- Resistance Level
- PESI $11.34
- INBX $15.25
- Average True Range (ATR)
- PESI 0.35
- INBX 1.10
- MACD
- PESI 0.09
- INBX 0.66
- Stochastic Oscillator
- PESI 90.77
- INBX 95.32
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.